Dudediligence.

Twist Bioscience Corporation

TWSTNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

62.7M

on 2026-06-30, from 58.2M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

2 of its filings are not read yet.

Warrants

The 10-Q filed 2026-08-03 is not read yet.

Cash

12.6 quarters

$166.8M on 2026-06-30 ÷ $13.3M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-08-04Public offeringnot read$96.00$300.0M424B5 ↗